Dendreon Option Premiums Remain Astronomical
May 8, 2007 · Filed Under General
by Jon C. Ogg
24/7 Wall St.
Dendreon (DNDN-NASDAQ) has only up to 4 full trading before that May 15 FDA review date. The funny thing here is that the options have actually become more expensive since reporting on this last week. The current $17.50 straddle would run $12.90 for the May expiration on the Put and Call strike prices.
Continue article at 247WallSt.com
RELATED READING:
- Dendreon, A Biotech Gift That Keeps On Giving!
- Dendreon’s New ‘Hold’ Rating at A.G.Edwards
- Dendreon: Countdown to FDA
______________________
Comments
Leave a Reply
You must be logged in to post a comment.